in past times couple of years, the UK has witnessed a revolution in health-related bodyweight‑decline treatment plans — with the introduction of semaglutide (Wegovy®) on the increasing reputation of tirzepatide (Mounjaro®). Now, One more name is drawing attention in both medical and community hea